Rhumbline Advisers Acquires 1,011 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Rhumbline Advisers lifted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 0.4% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 267,288 shares of the company’s stock after purchasing an additional 1,011 shares during the period. Rhumbline Advisers owned 0.31% of HealthEquity worth $25,646,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Louisiana State Employees Retirement System lifted its stake in shares of HealthEquity by 0.4% during the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company’s stock valued at $2,322,000 after acquiring an additional 100 shares during the period. Raymond James Trust N.A. lifted its stake in shares of HealthEquity by 4.8% during the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock valued at $238,000 after acquiring an additional 132 shares during the period. UMB Bank n.a. lifted its stake in shares of HealthEquity by 65.6% during the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after acquiring an additional 164 shares during the period. Nicolet Advisory Services LLC lifted its stake in shares of HealthEquity by 5.8% during the third quarter. Nicolet Advisory Services LLC now owns 4,218 shares of the company’s stock valued at $330,000 after acquiring an additional 233 shares during the period. Finally, Exchange Traded Concepts LLC lifted its stake in shares of HealthEquity by 2.6% during the fourth quarter. Exchange Traded Concepts LLC now owns 9,813 shares of the company’s stock valued at $942,000 after acquiring an additional 245 shares during the period. Institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Up 0.4 %

Shares of HealthEquity stock opened at $113.74 on Thursday. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59. The business has a 50-day moving average of $103.06 and a two-hundred day moving average of $91.63. The company has a market capitalization of $9.86 billion, a P/E ratio of 104.35, a price-to-earnings-growth ratio of 1.62 and a beta of 0.55. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period in the prior year, the company earned $0.40 EPS. As a group, equities analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. The Goldman Sachs Group assumed coverage on HealthEquity in a research note on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price on the stock. Mizuho assumed coverage on HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price on the stock. Bank of America increased their target price on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. BTIG Research increased their target price on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. Finally, Barrington Research increased their target price on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Monday, December 2nd. One research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, HealthEquity has an average rating of “Moderate Buy” and a consensus price target of $110.71.

Insider Buying and Selling

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares in the company, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Stuart B. Parker sold 25,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the transaction, the director now owns 19,061 shares of the company’s stock, valued at approximately $1,843,579.92. This represents a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 39,000 shares of company stock worth $3,895,788. 2.20% of the stock is owned by corporate insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.